PriceTargets.com logo

Victrex - VCT Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 2,163.33
  • Forecasted Upside: 20.12%
  • Number of Analysts: 3
  • Breakdown:
  • 0 Sell Ratings
  • 1 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
GBX 1,801 As of 01/27/2023 01:00 AM ET
▼ -1 (-0.06%)

This chart shows the closing price for VCT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Victrex Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for VCT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for VCT

Analyst Price Target is GBX 2,163.33
▲ +20.12% Upside Potential
This price target is based on 3 analysts offering 12 month price targets for Victrex in the last 3 months. The average price target is GBX 2,163.33, with a high forecast of GBX 2,300 and a low forecast of GBX 2,000. The average price target represents a 20.12% upside from the last price of GBX 1,801.

This chart shows the closing price for VCT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 3 polled investment analysts is to buy stock in Victrex. This rating has held steady since September 2022, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
8/5/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
11/3/2021
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
2/1/2022
  • 0 strong buy ratings
  • 6 buy ratings
  • 4 hold ratings
  • 0 sell ratings
Ratings as of
5/2/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 0 sell ratings
Ratings as of
7/31/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
10/29/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
Ratings as of
12/28/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
1/27/2023

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 1 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
12/7/2022BarclaysReiterated RatingOverweightGBX 2,190
10/10/2022JPMorgan Chase & Co.Lower TargetOverweightGBX 2,800 ➝ GBX 2,300
7/14/2022Berenberg BankReiterated RatingHoldGBX 2,000
7/13/2022BarclaysBoost TargetOverweightGBX 2,140 ➝ GBX 2,190
7/5/2022BarclaysLower TargetOverweightGBX 2,200 ➝ GBX 2,140
6/16/2022BarclaysUpgradeOverweightGBX 2,060 ➝ GBX 2,200
5/9/2022Berenberg BankLower TargetHoldGBX 2,200 ➝ GBX 2,000
1/26/2022Morgan StanleyReiterated RatingEqual WeightGBX 2,330
12/20/2021BarclaysLower TargetEqual WeightGBX 2,140 ➝ GBX 2,060
12/7/2021Berenberg BankReiterated RatingHoldGBX 2,600
10/27/2021BarclaysLower TargetEqual WeightGBX 2,150 ➝ GBX 2,140
8/26/2021Liberum CapitalBoost TargetHoldGBX 2,300 ➝ GBX 2,800
7/29/2021BarclaysBoost TargetEqual WeightGBX 1,870 ➝ GBX 2,150
7/12/2021Berenberg BankBoost TargetHoldGBX 2,500 ➝ GBX 2,600
7/9/2021Peel HuntBoost TargetBuyGBX 2,600 ➝ GBX 2,860
7/9/2021Peel HuntBoost TargetBuyGBX 2,600 ➝ GBX 2,860
6/30/2021Credit Suisse GroupBoost TargetOutperformGBX 2,700 ➝ GBX 2,900
6/4/2021Numis SecuritiesUpgradeAddGBX 2,800
5/11/2021JPMorgan Chase & Co.UpgradeOverweightGBX 2,150 ➝ GBX 2,800
5/7/2021Stifel NicolausReiterated RatingBuy
4/7/2021Liberum CapitalReiterated RatingHold
2/15/2021JPMorgan Chase & Co.Boost TargetNeutralGBX 2,000 ➝ GBX 2,150
8/24/2020BarclaysReiterated RatingUnderweightGBX 1,680
7/22/2020Morgan StanleyLower TargetUnderweightGBX 1,750 ➝ GBX 1,700
7/9/2020Berenberg BankReiterated RatingHoldGBX 2,000
7/8/2020UBS GroupReiterated RatingSellGBX 1,700 ➝ GBX 1,650
7/8/2020Liberum CapitalReiterated RatingHold
7/8/2020Peel HuntReiterated RatingHold
6/26/2020Liberum CapitalReiterated RatingHold
6/26/2020Credit Suisse GroupReiterated RatingOutperform
6/24/2020BarclaysLower TargetUnderweightGBX 1,690 ➝ GBX 1,660
6/18/2020CitigroupReiterated RatingSell
6/11/2020Peel HuntReiterated RatingHold
6/1/2020Liberum CapitalDowngradeHoldGBX 2,600 ➝ GBX 2,100
5/21/2020CitigroupReiterated RatingSellGBX 1,750
5/20/2020Peel HuntReiterated RatingHold
5/19/2020Jefferies Financial GroupUpgradeBuyGBX 2,320 ➝ GBX 2,200
5/12/2020Credit Suisse GroupReiterated RatingOutperformGBX 2,400
5/12/2020UBS GroupReiterated RatingSell
5/7/2020BarclaysLower TargetUnderweightGBX 1,740 ➝ GBX 1,690
5/6/2020Peel HuntReiterated RatingHold
4/24/2020Liberum CapitalReiterated RatingBuyGBX 2,600
4/8/2020Credit Suisse GroupLower TargetOutperformGBX 2,500 ➝ GBX 2,400
4/8/2020UBS GroupReiterated RatingSellGBX 2,250 ➝ GBX 1,700
4/7/2020BarclaysLower TargetUnderweightGBX 1,870 ➝ GBX 1,740
4/7/2020Peel HuntReiterated RatingHold
4/6/2020Berenberg BankLower TargetHoldGBX 2,200 ➝ GBX 2,000
4/1/2020Credit Suisse GroupLower TargetOutperformGBX 2,700 ➝ GBX 2,500
3/24/2020JPMorgan Chase & Co.Lower TargetNeutralGBX 2,150 ➝ GBX 1,750
3/23/2020Liberum CapitalReiterated RatingBuy
3/17/2020Peel HuntReiterated RatingHold
3/6/2020BarclaysDowngradeUnderweightGBX 1,940 ➝ GBX 1,870
2/19/2020Peel HuntBoost TargetHoldGBX 2,150 ➝ GBX 2,300
2/18/2020UBS GroupReiterated RatingSell
2/10/2020Credit Suisse GroupReiterated RatingOutperform
2/6/2020Peel HuntReiterated RatingHold
1/24/2020Morgan StanleyBoost TargetUnderweightGBX 1,800 ➝ GBX 1,950
1/22/2020UBS GroupDowngradeSellGBX 2,150 ➝ GBX 2,250
1/14/2020Berenberg BankReiterated RatingHold
12/6/2019UBS GroupReiterated RatingNeutral
12/5/2019Peel HuntReiterated RatingHold
12/5/2019Liberum CapitalReiterated RatingBuy
11/27/2019BarclaysLower TargetEqual weightGBX 2,020 ➝ GBX 1,940
11/25/2019UBS GroupReiterated RatingNeutral
11/12/2019Credit Suisse GroupReiterated RatingOutperform
11/11/2019UBS GroupReiterated RatingNeutral
10/7/2019Liberum CapitalReiterated RatingBuy
9/27/2019Stifel NicolausDowngradeHoldGBX 2,255 ➝ GBX 2,125
9/16/2019Peel HuntReiterated RatingHold
9/2/2019Credit Suisse GroupInitiated CoverageOutperformGBX 2,700
8/22/2019Liberum CapitalReiterated RatingBuy
8/21/2019BarclaysUpgradeEqual WeightGBX 2,020
7/26/2019UBS GroupReiterated RatingNeutral
7/25/2019Liberum CapitalReiterated RatingBuy
7/22/2019Peel HuntReiterated RatingHold
7/19/2019UBS GroupReiterated RatingNeutral
7/15/2019Peel HuntReiterated RatingHold
7/11/2019UBS GroupReiterated RatingNeutralGBX 2,225 ➝ GBX 2,150
7/5/2019JPMorgan Chase & Co.Lower TargetNeutralGBX 2,300 ➝ GBX 2,150
7/5/2019Peel HuntDowngradeHoldGBX 2,350 ➝ GBX 2,150
6/28/2019BarclaysReiterated RatingUnderweightGBX 2,150 ➝ GBX 1,900
6/24/2019UBS GroupReiterated RatingNeutral
6/17/2019Peel HuntReiterated RatingAdd
6/11/2019Peel HuntLower TargetAddGBX 2,500 ➝ GBX 2,350
6/5/2019Credit Suisse GroupReiterated RatingOutperformGBX 3,000
6/3/2019UBS GroupReiterated RatingNeutral
5/21/2019Berenberg BankLower TargetHoldGBX 2,550 ➝ GBX 2,250
5/20/2019Stifel NicolausInitiated CoverageBuyGBX 2,255
5/20/2019HSBCLower TargetHoldGBX 2,520 ➝ GBX 2,200
5/15/2019Liberum CapitalLower TargetBuyGBX 2,700 ➝ GBX 2,600
5/14/2019JPMorgan Chase & Co.Lower TargetNeutralGBX 2,800 ➝ GBX 2,300
5/14/2019UBS GroupReiterated RatingNeutralGBX 2,575 ➝ GBX 2,225
5/13/2019Numis SecuritiesReiterated RatingHoldGBX 2,550 ➝ GBX 2,350
5/13/2019Peel HuntReiterated RatingAdd
5/8/2019UBS GroupDowngradeNeutralGBX 2,850 ➝ GBX 2,575
5/6/2019Peel HuntReiterated RatingAdd
3/29/2019BarclaysReiterated RatingUnderweightGBX 2,420 ➝ GBX 2,210
3/27/2019Peel HuntReiterated RatingAdd
2/7/2019Berenberg BankLower TargetHoldGBX 2,600 ➝ GBX 2,550
2/6/2019Peel HuntReiterated RatingAddGBX 2,850 ➝ GBX 2,500
2/5/2019Liberum CapitalReiterated RatingBuy
2/1/2019JPMorgan Chase & Co.Reiterated RatingNeutral
1/10/2019Liberum CapitalLower TargetBuyGBX 2,825 ➝ GBX 2,700
1/8/2019HSBCReiterated RatingHold
1/4/2019Peel HuntReiterated RatingAdd
1/2/2019UBS GroupReiterated RatingBuy
12/13/2018HSBCLower TargetHoldGBX 2,650 ➝ GBX 2,520
12/11/2018Berenberg BankDowngradeHoldGBX 2,900 ➝ GBX 2,600
12/11/2018Peel HuntReiterated RatingAdd
12/6/2018UBS GroupReiterated RatingBuyGBX 3,600 ➝ GBX 3,200
12/5/2018BarclaysReiterated RatingUnderweightGBX 2,420
12/4/2018Peel HuntReiterated RatingAdd
10/16/2018Liberum CapitalReiterated RatingBuy
10/12/2018Morgan StanleyDowngradeUnderweightGBX 2,500 ➝ GBX 2,300
10/4/2018UBS GroupReiterated RatingBuyGBX 3,300 ➝ GBX 3,600
7/25/2018Peel HuntReiterated RatingAdd
7/25/2018Liberum CapitalReiterated RatingBuyGBX 2,825
7/24/2018BarclaysReiterated RatingUnderweightGBX 2,300 ➝ GBX 2,380
7/17/2018CitigroupReiterated RatingNeutral
7/16/2018Morgan StanleyBoost TargetEqual weightGBX 1,600 ➝ GBX 2,980
5/23/2018HSBCInitiated CoverageHoldGBX 2,650
5/17/2018Peel HuntUpgradeAddGBX 2,400 ➝ GBX 2,850
5/15/2018Credit Suisse GroupBoost TargetOutperformGBX 2,800 ➝ GBX 2,850
5/15/2018JPMorgan Chase & Co.Reiterated RatingNeutral
5/14/2018Peel HuntReiterated RatingHold
5/14/2018Liberum CapitalReiterated RatingBuy
5/8/2018Peel HuntReiterated RatingHoldGBX 2,400
4/9/2018Peel HuntReiterated RatingHold
4/5/2018BNP ParibasReiterated RatingUnderperform
4/3/2018Liberum CapitalReiterated RatingBuy
3/28/2018Credit Suisse GroupBoost TargetOutperformGBX 2,650 ➝ GBX 2,800
2/23/2018Berenberg BankBoost TargetBuyGBX 1,320 ➝ GBX 1,380
2/12/2018Numis SecuritiesReiterated RatingHoldGBX 2,300 ➝ GBX 2,550
2/12/2018Peel HuntReiterated RatingHoldGBX 2,400
2/6/2018Peel HuntBoost TargetHoldGBX 2,300 ➝ GBX 2,400
2/5/2018Liberum CapitalReiterated RatingBuyGBX 2,770
1/30/2018Liberum CapitalReiterated RatingBuyGBX 2,770
(Data available from 1/28/2018 forward)

News Sentiment Rating

0.49 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
7/2/2022
  • 1 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Mentions as of
8/1/2022
  • 0 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
8/31/2022
  • 0 very positive mentions
  • 5 positive mentions
  • 2 negative mentions
  • 2 very negative mentions
Mentions as of
9/30/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/30/2022
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/29/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/29/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/28/2023

Current Sentiment

  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Victrex logo
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company operates through two segments, Industrial and Medical. It develops PEEK and PAEK polymer solutions, and semi-finished and finished parts. The company also offers specialist solutions for medical device manufacturers; sells thermoplastic polymer components; and engages in trading activities. It serves automotive, aerospace, energy and industrial, manufacturing and engineering, electronics, and medical markets. Victrex plc was founded in 1993 and is headquartered in Thornton-Cleveleys, the United Kingdom.
Read More

Today's Range

Now: GBX 1,801
Low: 1,786
High: 1,847.02

50 Day Range

MA: GBX 1,696.05
Low: 1,545
High: 1,829

52 Week Range

Now: GBX 1,801
Low: 1,522
High: 2,098

Volume

84,456 shs

Average Volume

182,188 shs

Market Capitalization

£1.57 billion

P/E Ratio

2,251.25

Dividend Yield

3.31%

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Victrex?

The following sell-side analysts have issued research reports on Victrex in the last year: Barclays PLC, Berenberg Bank, and JPMorgan Chase & Co..
View the latest analyst ratings for VCT.

What is the current price target for Victrex?

3 Wall Street analysts have set twelve-month price targets for Victrex in the last year. Their average twelve-month price target is GBX 2,163.33, suggesting a possible upside of 20.1%. JPMorgan Chase & Co. has the highest price target set, predicting VCT will reach GBX 2,300 in the next twelve months. Berenberg Bank has the lowest price target set, forecasting a price of GBX 2,000 for Victrex in the next year.
View the latest price targets for VCT.

What is the current consensus analyst rating for Victrex?

Victrex currently has 1 hold rating and 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe VCT will outperform the market and that investors should add to their positions of Victrex.
View the latest ratings for VCT.

What other companies compete with Victrex?

Other companies that are similar to Victrex include Elementis, Synthomer, Scapa Group, Johnson Matthey and Genuit Group. Learn More about companies similar to Victrex.

How do I contact Victrex's investor relations team?

Victrex's physical mailing address is Victrex Technology Centre , Hillhouse International,, THORNTON CLEVELEYS, FY5 4QD, United Kingdom. The company's listed phone number is +44-1253-897700. The official website for Victrex is www.victrexplc.com. Learn More about contacing Victrex investor relations.